Dow Up0.48% Nasdaq Up0.43%

Inovio Pharmaceuticals, Inc. (INO)

-NYSE MKT
9.94 0.08(0.81%) Aug 19, 4:01PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 13,467   4,119   9,795  
Cost of Revenue -   -   -  
Gross Profit 13,467   4,119   9,795  
Operating Expenses
Research Development21,369  17,985  20,032  
Selling General and Administrative13,643  10,778  11,989  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (19,544) (23,494) (21,639)
Income from Continuing Operations
Total Other Income/Expenses Net(44,539)4,932  6,921  
Earnings Before Interest And Taxes(64,084)(18,562)(14,717)
Interest Expense -   -   -  
Income Before Tax(64,084)(18,562)(14,717)
Income Tax Expense -   -   -  
Minority Interest55  44  51  
Net Income From Continuing Ops(64,028)(18,518)(14,666)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (66,028) (19,669) (15,253)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (66,028) (19,669) (15,253)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.